CenTrial Logo

Atorvastatin may Help Delay Arterial Stiffness in Dialysis Patients


Are statins useful in delaying arterial stiffness in kidney failure patients? A clinical trial investigates.

A clinical trial has explored the use of atorvastatin, a common medication used to lower cholesterol, in delaying the progression of blood vessel stiffness in hemodialysis patients.

Arterial stiffness is defined as the hardening of the blood vessels due to age or disease. It is a common complication of chronic kidney disease and end-stage renal failure, and it can lead to a range of cardiovascular problems, such as heart disease and stroke. Hemodialysis patients are particularly at risk of developing arterial stiffness due to their impaired kidney function.

In chronic kidney disease patients, reducing arterial stiffness is associated with improved survival. Many drugs have been studied to improve arterial stiffness with variable degrees of success including antihypertensive medications, anti-inflammatory drugs, endothelin-1 antagonists, antioxidants, immunosuppressive drugs, and statins.

Statins are drugs that are used to lower blood cholesterol levels. They generally have a beneficial effect on the heart and blood vessels. Their use is well documented in patients with diabetes, hypertension, and elevated blood fat levels however, clinical data on their use in kidney disease is deficient.

A clinical trial was published that aimed to investigate the potential benefits of atorvastatin in delaying the progression of arterial stiffness in dialysis patients.

The researchers recruited 50 chronic kidney disease patients undergoing regular dialysis and divided them into two groups: a treatment group that received atorvastatin for six months, and a control group that did not receive the medication. The researchers measured the participants' arterial stiffness at the beginning of the study and again at the end of the six-month treatment period.

Are you interested in clinical trials near you?

You can receive free notification of a trial for this, or any other condition, by completing a short confidential health profile.
Find a clinical trial near me
The results of the clinical trial showed that the blood vessel stiffness was similar before and after treatment with atorvastatin. On the other hand, arterial stiffness increased in patients who did not receive atorvastatin. This lead the researchers to deduce that atorvastatin had a protective effect on the blood vessels as it delayed the progression of arterial stiffness in these patients.

The findings of this clinical study have important implications as they suggest that atorvastatin may have additional benefits beyond its cholesterol-lowering effects. By reducing arterial stiffness, the medication may help improve cardiovascular outcomes in hemodialysis patients.

In summary, the clinical trial provides promising evidence that atorvastatin may be a valuable treatment option in kidney failure patients to delay the progression of arterial stiffness. This is an important finding, as arterial stiffness is a common complication of chronic kidney disease and can lead to serious cardiovascular problems. However, it is important to discuss all possible treatments with your healthcare provider.

Share this article with a friend:

Get emailed clinical trial results in the categories of your choice:
Free subscription to clinical trial results

20,000 clinical trials are seeking participants.
Signup and be matched to trials near you
This free service will notify you of current and future clinical trial matches.

This content is for informational and educational purposes only. It is not intended to provide medical advice or to take the place of such advice or treatment from a personal physician. All readers/viewers of this content are advised to consult their doctors or qualified health professionals regarding specific health questions. CenTrial Data Ltd. does not take responsibility for possible health consequences of any person or persons reading or following the information in this educational content. Treatments and clinical trials mentioned may not be appropriate or available for all trial participants. Outcomes from treatments and clinical trials may vary from person to person. Consult with your doctor as to whether a clinical trial is a suitable option for your condition. Assistance from generative AI tools may have been used in writing this article.